Skip to content

Physical Exercise Training Programme COPD in Primary care

Physical Exercise Training Programme COPD in Primary care - Physical Exercise Training Programme in COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35671
Enrollment
170
Registered
2008-11-26
Start date
2010-05-31
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

"smokers lung" chronic bronchitis and emphysema

Interventions

The intervention group will participate in a 4-month physical exercise training programme in a physiotherapy setting. This programme consists of a combination of endurance/interval training, resista

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: COPD patients visiting their general practitioner because of dyspnoea, impaired exercise capacity and/or a reduced quality of life. COPD patients who have a clinical diagnosis of mild to moderate COPD (supported by FEV1/FVC ratio 50% of predicted post-bronchodilator) and MRC-score >= 2. And not meeting the level of exercise performance as defined by the Dutch Standard of Healthy Physical Exercise.

Exclusion criteria

Exclusion criteria: Patients who already receive or have received a physical exercise training programme or rehabilitation therapy in the past year. Patients who have had respiratory tract infections within the last 8 weeks. Presence of serious co morbid conditions which would interfere with regular exercise training - severe orthopaedic, muscular, or neurological disorders - cardiovascular conditions liable to be aggravated by exercise

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be the functional exercise capacity measured by the increase in 6MWD at 4 months compared to baseline.

Secondary

MeasureTime frame
Secondary outcome measures will be peripheral muscle strength (measured with a handheld dynamometer), physical activity (assessed by a pedometer/accelerometer), specific health related quality of life (assessed by questionnaires) and global perceived effect of the treatment according to the patients (measured on a GPE scale). There will also be some exploratory outcome measures, for example lung function, general health status, motivation and some safety and feasibility parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)